Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture

The emerging SARS-CoV-2 infection associated with the outbreak of viral pneumonia in China is ongoing worldwide. There are no approved antiviral therapies to treat this viral disease. Here we examined the antiviral abilities of three broad-spectrum antiviral compounds gemcitabine, lycorine and oxyso...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Ya-Nan Zhang, Qiu-Yan Zhang, Xiao-Dan Li, Jin Xiong, Shu-Qi Xiao, Zhen Wang, Zhe-Rui Zhang, Cheng-Lin Deng, Xing-Lou Yang, Hong-Ping Wei, Zhi-Ming Yuan, Han-Qing Ye, Bo Zhang
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Taylor & Francis Group 2020-01-01
Schriftenreihe:	Emerging Microbes and Infections
Schlagworte:	Novel coronavirus alkaloid broad-spectrum antiviral 2019-nCoV SARS-CoV-2
Online-Zugang:	https://www.tandfonline.com/doi/10.1080/22221751.2020.1772676
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!